Physician profile

Arley A Peter

Cardiovascular Disease · Vero Beach, FL

NPI 1952515116

$52,572.38

in general payments reported to CMS, 2019-2025

44 companies · $5,414 in 2025

The $5,414 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$12,500.00
Food and Beverage$7,486.33

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $41,158.35 2019-2025 Lifevest
Medtronic Vascular, INC. $1,939.32 2019-2020
Abbott Laboratories $1,087.76 2020-2025 Mitraclip, Amplatzer Amulet, Aveir
Medtronic, INC. $1,011.56 2021-2025 Venaseal, Closurefast, Micra
Boston Scientific Corporation $749.66 2019-2025 Watchman Flx, Lux-Dx Insertable Cardiac Monitor
Novartis Pharmaceuticals Corporation $555.44 2019-2025
Amgen INC. $465.01 2019-2025 Repatha, Repatha
Astrazeneca Pharmaceuticals LP $463.36 2019-2025 Farxiga, Lokelma
Biotronik INC. $462.90 2021-2025 Biomonitor, Acticor 7 Vr-T Dx, Renamic Neo
Pfizer INC. $449.17 2019-2024
Merck Sharp & Dohme LLC $408.67 2023-2025 Verquvo
Boehringer Ingelheim Pharmaceuticals, INC. $350.04 2019-2025 Jardiance
Novo Nordisk INC $349.77 2023-2025 Wegovy, Ozempic
Sanofi-Aventis U.S. LLC $348.30 2019-2024
E.R. Squibb & Sons, L.L.C. $329.95 2019-2025 Camzyos, Eliquis
Show all 44 companies
CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $260.00 2019-2024 Xarelto
Cvrx, INC. $235.57 2023-2025 Barostim Neo System
Lexicon Pharmaceuticals, INC. $217.62 2023-2024 Inpefa
Bayer Healthcare Pharmaceuticals INC. $208.12 2021-2025
Edwards Lifesciences Corporation $202.06 2024-2025 Sapien 3 Ultra Resilia
Kestra Medical Technology Services, INC. $177.87 2024-2025 Assure Wcd
Amarin Pharma, INC. $145.23 2019-2020
Akcea Therapeutics, INC. $125.00 2020
Esperion Therapeutics, INC. $112.67 2020-2025 Nexletol
Kiniksa Pharmaceuticals, LTD. $97.85 2022-2023 Arcalyst
Regeneron Healthcare Solutions, INC. $82.73 2019-2025 Evkeeza, Praluent
Resmed Corp $75.79 2023
Heartflow, INC. $68.33 2025
Infobionic, INC $55.03 2021-2025 Mome Device
Kiniksa Pharmaceuticals International, Plc $52.73 2024 Arcalyst
Glaxosmithkline, LLC. $38.11 2025 Shingrix, Arexvy
Philips North America LLC $37.58 2025 Extended Holter, Event
Irhythm Technologies, INC. $34.45 2020-2024 Zio Xt Patch, Zio Monitor
Impulse Dynamics (USA) INC. $26.65 2023 Optimizer
Vital Connect, INC $25.63 2025 Vitalpatch Rtm
United Therapeutics Corporation $25.60 2024 Tyvaso
Bardy Diagnostics, INC. $25.00 2020-2022
Vivaquant INC, Dba Rhythm Express $22.16 2024 Rhythm Express
Atricure, INC. $18.02 2024
Lilly USA, LLC $17.99 2025 Mounjaro
Baxter Healthcare $16.24 2023 Hillrom - Cardiac Ambulatory Monitor
Tactile Systems Technology INC $13.41 2023 Entre Plus, Flexitouch Plus
Coala Life INC $13.00 2020
Allergan, INC. $12.68 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Arley A Peter

$52,572.38

in general payments reported 2019-2025

Years
2019-2025
Top company
Zoll Services LLC (A/K/A Zoll Lifecor Corp)
Context
The $5,414 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/134275/arley-a-peter

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.